INTRODUCTION AND OBJECTIVES: Urethral strictures are scars of urethral epithelium, which can cause an obstructive voiding dysfunction with consecutive damage of the upper urinary tract. Almost 45% of all strictures are iatrogenic. Strictures occur in up to 2-9% after radical prostatectomy, but can also occur after radiotherapy for prostate cancer. This study provides 5-year data of a certified prostate-cancercentre (PKZ) for the endpoint urethral stricture.
METHODS: Between 01/2008 and 12/2012 a total of 519 men were irradiated for prostate cancer (LDR-and HDR-brachytherapy as well as external beam radiation). The entire cohort was followed-up prospectively according to a standardized protocol (stratified by type of irradiation). Short segment urethral strictures were treated by urethrotomy, recurrent and long segment stenosis with buccal mucosa urethroplasty.
RESULTS: Overall, 18 out of 519 (3.4%) patients developed a urethral stricture post-therapeutically, which recurred in 66% of cases after the first operative treatment. The largest risk for developing a urethral stricture is attributed to the HDR-brachytherapy (8.9%). 2/82 (2,4%) patients after LDR-brachytherapy developed urethral strictures; 2/279 (0,7%) patients after external beam radiation suffered from strictures.
CONCLUSIONS: Urethral strictures after radiotherapy for prostate cancer should be diagnosed and treated in a timely fashion to prevent loss of renal function. The rate of radiogenic urethral strictures (3.4%) is equivalent to those after radical prostatectomy. Due to a high rate of recurrences, urethrotomy has a limited importance after irradiation.
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PD72-12 SEER ANALYSIS OF RISK OF BLADDER, RECTUM AND COLON CANCER AFTER RADIOTHERAPY FOR PROSTATE CANCER IN YOUNGER AND OLDER MEN
Diana Lopategui*, Raymond Balise, Marcelo Panizzutti, Sanoj Punnen, Miami, FL INTRODUCTION AND OBJECTIVES: Despite improvements in various forms of radiotherapy for prostate cancer over the past 20 years, secondary malignancies remain a concern, especially amongst younger patients. We analyzed a population-based cancer database to compare the risk of bladder, rectum and colon cancer after definitive treatment of prostate cancer with external beam radiotherapy (EBRT) or brachytherapy (BT) compared to surgery; and assessed its differential impact by age at diagnosis.
METHODS:
We analyzed a cohort of 198,738 men from the SEER database diagnosed with localized prostate cancer between 1993 and 2013. We used Cox regression models and to assess the association between BT and EBRT vs. surgery and the likelihood of developing subsequent bladder, rectum or colon cancer 2 or more years after treatment. For subgroup analyses, we separately analyzed these associations in men who were below and above the age of 65 years using a similar analysis. To help account for multiple comparisons p values < .005 were considered statistically significant.
RESULTS: The incidence of secondary malignancies was low in all groups (~4.3%). All three sites showed a statistically significant (p < 0.0001) increase in the hazard of secondary cancers compared to surgery (colon HR: 1.46, 95%, CL: 1.36 -1.57; rectum HR: 1.78, 95%, CL: 1.59 -1.99; bladder HR: 2.19, 95%, CL: 2.05 -2.34). While exposure to radiation was associated with increased hazards in both younger and older men, consistently higher hazards were seen in the younger cohort. We found that EBRT was associated with a higher risk of cancer at all sites in both younger and older men, but BT was not associated with an increased risk of colon or rectal (Table 1) .
CONCLUSIONS: Incidence of bladder, rectum and colon cancer is significantly increased after treatment of prostate cancer with radiotherapy compared to surgery. Effects are observed regardless of age, and worse in men who are younger and those receiving EBRT. INTRODUCTION AND OBJECTIVES: Renal mass biopsy (RMB) provides important information about the aggressiveness of renal tumors and helps urologists in the treatment decision-making process. Although tumor tract seeding is exceedingly rare, we questioned whether tumor capsule violation from RMB is associated with increased risk of perinephric fat invasion. In this study, we evaluated the association between RMB and perinephric fat invasion e1366 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 in patients with localized RCC who underwent partial or radical nephrectomy. METHODS: We reviewed the National Cancer Database from 2004-2013 and identified patients who underwent partial nephrectomy (PN) or radical nephrectomy (RN) for clinical T1a, T1b, and T2a tumors. Patients were classified as upstaged if final pathology demonstrated perinephric invasion only. Patients who received neoadjuvant systemic treatment, those with clinically node positive disease, and tumors with renal sinus fat invasion were excluded. Logistic regression analysis was used to identify predictors of perinephric fat invasion. Descriptive statistics were then used to compare patient demographics and tumor characteristics between those with RMB and those without RMB.
Source of Funding: None
RESULTS: A total of 56,557 patients met our inclusion criteria. Pathologic upstaging to pT3a disease occurred in 3.7% of patients, of which 2.1% (1,191/56,557) had perinephric fat invasion only. RMB was performed in 3,740 (6.6%) patients. Age 70, Caucasian race, Charlson-Deyo score 2, and tumor size 4cm were associated with higher utilization of RMB. Perinephric fat invasion was identified in 2.0% of patients without RMB and in 2.9% of patients with RMB. Logistic regression demonstrated a significant association between RMB and perinephric fat invasion (OR 1.51, 95% CI 1.24 -1.85) after controlling for confounders. As an additional control, RMB was not found to be associated with risk of upstaging to renal sinus fat invasion.
CONCLUSIONS: Perinephric fat invasion on final pathology is a rare finding in patients with clinically localized renal tumors. Although performed for relatively smaller tumors, RMB is associated with risk of upstaging to pT3a disease and this is limited to perinephric fat invasion. This finding may be secondary to pathologic artifact or confounding variables not accounted for in our multivariable model. Prospective studies to evaluate cancer specific outcomes, such as recurrence, are warranted to further investigate the clinical relevance of these findings. METHODS: This retrospective review included all patients undergoing RN for RCC measuring <10 cm with a normal contralateral kidney between January 1, 2011 -May 1, 2015. All slides were independently re-reviewed for histopathologic changes using the Banff 97 criteria by two blinded nephropathologists for any chronic glomerular (G), tubulointerstitial (IFTA), arterial (Art), and arteriolar changes (Arl). Univariate analyses were conducted with Spearman correlation coefficients and ANOVA. Factors significantly associated with post-operative eGFR were entered into multivariable regression (MVR) models. Separate regression models were created for the clinical and histological factors. Predictive performance was evaluated with the r-square statistic. Estimated glomerular rate (eGFR) was calculated using chronic kidney disease epidemiology collaboration formula.
RESULTS: The 167 patients had a mean age, Charlson comorbidity score, and tumor size of 61, 2.6, and 6.2cm, respectively. The group consisted of diabetics (26%), hypertensives (60%), and smokers (35%). Mean pre-op eGFR and 24-month eGFR were 78 and 51mL/min/1.73m 2 , respectively. Severe histopathologic changes were discovered in 11% of patients despite normal preoperative eGFRs. New kidney disease was common (54%); 8 patients progressed to dialysis and 20 died during follow-up. NNK changes were significantly associated post-op eGFR at 1 year (R2¼0.52) and 2 years (R2¼0.5). Severe G and IFTA were associated with an independent eGFR change of decline of -28 (p<0.001) and -16 mL/min/1.73m 2 (p¼0.0005). Art (p¼0.08) and Arl (p¼0.387) changes were not associated with eGFR changes. Age (p<0.0001), body mass index (p¼0.0039), and age-adjusted Charlson co-morbidity (p¼0.0434) were significantly associated with postop eGFR. Using MVR modeling a calculator was developed and accurately predicted post-op eGFR.
CONCLUSIONS: Using age, glomerular, and tubulointerstitial histopathologic variables alone, the post-operative eGFR can be accurately calculated. This calculator may guide studies on subsequent therapeutic intervention following radical or partial nephrectomy. In some recent studies, RV wall invasion is suggested as a predictor of poor outcomes. In this study, we sought to determine the impact of renal vein wall invasion on the risk of recurrence and death in patients with RCC and caval tumor thrombus.
METHODS: A cohort of 257 patients with non-metastatic RCC and level II-IV IVC thrombus who underwent surgery between 1990-2015 at our institution were studied. Patient demographics, clinical, pathological features including renal and IVC wall invasion, and outcomes information were obtained. Univariable and Multivariable Cox-proportional hazard model were used for analysis.
RESULTS: Median age of the cohort at surgery was 64 years. A total of 45% patients had renal artery embolization prior to surgery. On preoperative imaging tumor thrombus level was noted as level 2 in 112 patients (42%), level 3 in 90 patients (35%) and level 4 in 51 patients (20%). A total of 35% had recurrence with mean time to recurrence of 15 months. At mean follow up time of 21 months, 53% were alive. Main RV and IVC wall invasion was present in 57% and 15% patients respectively. On univariable analysis, microscopic main RV wall invasion was not significantly associated with increased risk of recurrence (Hazard ratio[HR]¼1.13) or death (HR¼1.07) (both p>0.05). Invasion of IVC wall was associated with increased risk of recurrence (HR¼1.9, p<0.05) but was not significantly associated with increased risk of death (HR¼0.87, p¼0.7). Lower preoperative hemoglobin, need for bypass, need for blood transfusion, older age, and longer operative time were associated with poor survival (all p<0.05).
CONCLUSIONS: Main RV wall invasion is present in significant proportion of patients with non-metastatic RCC with IVC tumor thrombus, however, in our cohort it was not associated with increased risk of recurrence or death. Main RV wall invasion should be reported by the pathologist until the impact of this finding is clearly defined.
